← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

STVN logoStevanato Group S.p.A.(STVN)Earnings, Financials & Key Ratios

STVN•NYSE
$19.00
$5.19B mkt cap·33.0× P/E·Price updated May 6, 2026
SectorHealthcareIndustryMedical InstrumentsSub-IndustryDrug delivery and infusion consumables
AboutStevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.Show more
  • Revenue$1.14B+3.2%
  • EBITDA$268M+10.9%
  • Net Income$134M+14.0%
  • EPS (Diluted)0.49+14.0%
  • Gross Margin28.99%+5.9%
  • EBITDA Margin23.54%+7.5%
  • Operating Margin16.07%+10.1%
  • Net Margin11.78%+10.5%
  • ROE9.29%
  • ROIC7.71%+1.9%
  • Debt/Equity0.32+3.7%
  • Interest Coverage8.40-65.5%
Technical→

STVN Key Insights

Stevanato Group S.p.A. (STVN) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓High quality earnings: Operating CF exceeds net income
  • ✓Strong 5Y sales CAGR of 11.5%
  • ✓Healthy 5Y average net margin of 13.3%

✗Weaknesses

  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

STVN Price & Volume

Stevanato Group S.p.A. (STVN) stock price & volume — 10-year historical chart

Loading chart...

STVN Growth Metrics

Stevanato Group S.p.A. (STVN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years11.47%
3 Years5.02%
TTM7.16%

Profit CAGR

10 Years-
5 Years11.33%
3 Years-2.04%
TTM18.39%

EPS CAGR

10 Years-
5 Years11.84%
3 Years-2.58%
TTM16.76%

Return on Capital

10 Years13.7%
5 Years13.93%
3 Years11.34%
Last Year9.49%

STVN Recent Earnings

Stevanato Group S.p.A. (STVN) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 5/12 qtrs (42%)●Beat Revenue 3/12 qtrs (25%)
Q2 2026Latest
Mar 4, 2026
EPS
$0.21
Est $0.20
+5.0%
Revenue
$407M
Est $391M
+4.0%
Q4 2025
Nov 6, 2025
EPS
$0.16
Est $0.14
+14.3%
Revenue
$355M
Est $385M
-7.9%
Q3 2025
Aug 5, 2025
EPS
$0.12
Est $0.11
+9.1%
Revenue
$330M
Est $343M
-3.9%
Q2 2025
May 8, 2025
EPS
$0.11
Est $0.10
+10.0%
Revenue
$281M
Est $302M
-6.7%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMar 4, 2026
$0.21vs $0.20+5.0%
$407Mvs $391M+4.0%
Q4 2025Nov 6, 2025
$0.16vs $0.14+14.3%
$355Mvs $385M-7.9%
Q3 2025Aug 5, 2025
$0.12vs $0.11+9.1%
$330Mvs $343M-3.9%
Q2 2025May 8, 2025
$0.11vs $0.10+10.0%
$281Mvs $302M-6.7%
Based on last 12 quarters of dataView full earnings history →

STVN Peer Comparison

Stevanato Group S.p.A. (STVN) competitors in Drug delivery and infusion consumables — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
APOG logoAPOGApogee Enterprises, Inc.Direct Competitor783.61M36.4314.463.21%3.85%10.79%0.56
BCPC logoBCPCBalchem CorporationDirect Competitor5.17B161.3833.978.75%14.95%12.38%0.15
BDX logoBDXBecton, Dickinson and CompanyProduct Competitor52.45B144.7624.838.23%8.01%6.93%0.76
WST logoWSTWest Pharmaceutical Services, Inc.Product Competitor22.53B312.5545.966.26%16.85%17.87%0.13
GTLS logoGTLSChart Industries, Inc.Product Competitor9.94B207.76629.582.49%0.95%1.2%1.11
AVTR logoAVTRAvantor, Inc.Product Competitor5.76B8.43-10.81-3.41%-8.42%-9.59%0.71
AZTA logoAZTAAzenta, Inc.Product Competitor846.61M18.38-15.073.55%-29.86%-10.69%0.06
PFE logoPFEPfizer Inc.Supply Chain150.77B26.5119.49-1.65%11.83%8.34%0.78

Compare STVN vs Peers

Stevanato Group S.p.A. (STVN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs APOG

Most directly comparable listed peer for STVN.

Scale Benchmark

vs LLY

Larger-name benchmark to compare STVN against a more recognizable public peer.

Peer Set

Compare Top 5

vs APOG, BCPC, BDX, WST

STVN Income Statement

Stevanato Group S.p.A. (STVN) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Sales/Revenue536.54M662.04M843.92M983.68M1.09B1.1B1.14B
Revenue Growth %-23.39%27.47%16.56%10.34%1.72%3.21%
Cost of Goods Sold398.52M467.86M578.51M663.88M745.46M801.72M809.15M
COGS % of Revenue74.28%70.67%68.55%67.49%68.68%72.62%71.01%
Gross Profit
138.02M▲ 0%
194.18M▲ 40.7%
265.4M▲ 36.7%
319.8M▲ 20.5%
339.89M▲ 6.3%
302.32M▼ 11.1%
330.33M▲ 9.3%
Gross Margin %25.72%29.33%31.45%32.51%31.32%27.38%28.99%
Gross Profit Growth %-40.69%36.68%20.5%6.28%-11.05%9.26%
Operating Expenses75.8M91.07M103.18M127.37M139.17M141.18M147.25M
OpEx % of Revenue14.13%13.76%12.23%12.95%12.82%12.79%12.92%
Selling, General & Admin76.71M78.91M82.95M111.83M113.92M118.6M122.85M
SG&A % of Revenue14.3%11.92%9.83%11.37%10.5%10.74%10.78%
Research & Development7.83M17.39M29.62M34.39M35.67M31.67M24.4M
R&D % of Revenue1.46%2.63%3.51%3.5%3.29%2.87%2.14%
Other Operating Expenses-8.74M-5.23M-9.39M-18.85M-10.42M-9.09M0
Operating Income
62.22M▲ 0%
103.11M▲ 65.7%
162.22M▲ 57.3%
192.43M▲ 18.6%
200.72M▲ 4.3%
161.14M▼ 19.7%
183.08M▲ 13.6%
Operating Margin %11.6%15.57%19.22%19.56%18.49%14.6%16.07%
Operating Income Growth %-65.72%57.33%18.62%4.31%-19.72%13.61%
EBITDA108.44M157.21M218.61M257.25M279.2M241.79M268.18M
EBITDA Margin %20.21%23.75%25.9%26.15%25.72%21.9%23.54%
EBITDA Growth %-44.98%39.05%17.68%8.53%-13.4%10.91%
D&A (Non-Cash Add-back)46.22M54.1M56.38M64.82M78.48M80.65M85.1M
EBIT60.32M102.27M170.54M191.58M193.87M167.15M183.08M
Net Interest Income-5.1M-6.37M-4.32M-3.29M-3.52M-5.14M-9.32M
Interest Income195.87K424.07K548K648K792K1.72M12.49M
Interest Expense5.3M6.79M4.87M3.94M4.32M6.86M21.8M
Other Income/Expense-7.51M-6.83M3.45M-4.79M-11.17M-854K-1.44M
Pretax Income
54.71M▲ 0%
96.28M▲ 76.0%
165.67M▲ 72.1%
187.64M▲ 13.3%
189.55M▲ 1.0%
160.29M▼ 15.4%
181.64M▲ 13.3%
Pretax Margin %10.2%14.54%19.63%19.08%17.46%14.52%15.94%
Income Tax16.01M17.68M31.4M44.63M43.86M42.52M47.35M
Effective Tax Rate %29.26%18.37%18.96%23.78%23.14%26.53%26.07%
Net Income
39.2M▲ 0%
78.51M▲ 100.3%
134.32M▲ 71.1%
142.85M▲ 6.3%
145.63M▲ 1.9%
117.78M▼ 19.1%
134.28M▲ 14.0%
Net Margin %7.31%11.86%15.92%14.52%13.42%10.67%11.78%
Net Income Growth %-100.28%71.08%6.35%1.95%-19.13%14.01%
Net Income (Continuing)38.71M78.6M134.27M143.02M145.69M117.77M134.28M
Discontinued Operations0000000
Minority Interest-50K-355K-415K-220K115K46K37.98K
EPS (Diluted)
0.15▲ 0%
0.28▲ 86.7%
0.53▲ 89.3%
0.53▲ 0.0%
0.55▲ 3.8%
0.43▼ 21.8%
0.49▲ 14.0%
EPS Growth %-86.67%89.29%0%3.77%-21.82%13.95%
EPS (Basic)0.150.280.530.530.550.430.49
Diluted Shares Outstanding264.7M264.7M264.7M264.7M264.98M272.88M273M
Basic Shares Outstanding264.7M264.7M264.7M264.7M264.95M272.87M273M
Dividend Payout Ratio15.74%11.34%8.34%9.45%9.82%12.27%10.54%

STVN Balance Sheet

Stevanato Group S.p.A. (STVN) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Total Current Assets449.58M492.77M865.97M845.77M861.89M880.12M934.4M
Cash & Short-Term Investments126.27M157.12M438.21M256.65M70.35M98.27M132.74M
Cash Only85.39M115.6M411.04M228.74M69.6M98.27M130.54M
Short-Term Investments40.88M41.52M27.17M27.91M749K02.2M
Accounts Receivable160.58M167.25M278.42M369.48M522.48M529.87M542.17M
Days Sales Outstanding109.2492.21120.42137.1175.71175.18173.67
Inventory131.88M139.37M148.92M213.25M255.32M245.22M268.09M
Days Inventory Outstanding120.79108.7393.96117.25125.01111.64120.93
Other Current Assets30.55M28.62M49K5.69M3.63M933K-8.6M
Total Non-Current Assets432.6M475.2M552.87M813.92M1.21B1.45B1.61B
Property, Plant & Equipment306.93M339.04M415.41M660.69M1.05B1.26B1.4B
Fixed Asset Turnover1.75x1.95x2.03x1.49x1.04x0.87x0.81x
Goodwill47.24M47.24M47.24M47.24M49.98M49.98M49.96M
Intangible Assets34.82M33.9M31.93M32.16M30.98M33.59M36.85M
Long-Term Investments4.61M3.51M1.97M1.83M5.15M5.64M6M
Other Non-Current Assets5.9M5.96M447K2.79M577K08.6M
Total Assets
882.18M▲ 0%
967.98M▲ 9.7%
1.42B▲ 46.6%
1.66B▲ 17.0%
2.07B▲ 24.8%
2.33B▲ 12.4%
2.54B▲ 9.2%
Asset Turnover0.61x0.68x0.59x0.59x0.52x0.47x0.45x
Asset Growth %-9.73%46.58%16.98%24.82%12.42%9.19%
Total Current Liabilities262.94M316.18M338.62M462.5M574.39M477.47M535.57M
Accounts Payable95.05M118.74M164.79M239.18M277.81M231.02M263.19M
Days Payables Outstanding87.0692.63103.97131.5136.03105.18118.72
Short-Term Debt65.35M63.45M37.17M64.63M135.6M106.84M121.69M
Deferred Revenue (Current)50.43M56.9M50.61M53.89M58.8M44.67M43.78M
Other Current Liabilities10.83M17.49M5.33M-3.73M11.15M15.45M106.91M
Current Ratio1.71x1.56x2.56x1.83x1.50x1.84x1.74x
Quick Ratio1.21x1.12x2.12x1.37x1.06x1.33x1.24x
Cash Conversion Cycle142.97108.31110.41122.84164.69181.64175.88
Total Non-Current Liabilities353.8M341.66M238.56M201.29M364.54M446.96M521.38M
Long-Term Debt290.88M273.94M183.99M133.75M242.05M305.23M337.64M
Capital Lease Obligations21.26M20.19M17.57M14.66M13.1M11.81M9.37M
Deferred Tax Liabilities011.62M19.11M20.95M9.62M12.56M13.29M
Other Non-Current Liabilities41.66M35.92M17.89M31.93M60.35M73.32M62.07M
Total Liabilities616.74M657.84M577.18M663.79M938.93M924.43M1.06B
Total Debt375.67M363.01M244.29M218.37M396.59M428.97M470.7M
Net Debt290.28M247.41M-166.75M-10.37M326.99M330.7M340.16M
Debt / Equity1.42x1.17x0.29x0.22x0.35x0.31x0.32x
Debt / EBITDA3.46x2.31x1.12x0.85x1.42x1.77x1.76x
Net Debt / EBITDA2.68x1.57x-0.76x-0.04x1.17x1.37x1.27x
Interest Coverage11.38x15.06x35.01x48.67x44.93x24.35x8.40x
Total Equity
265.44M▲ 0%
310.14M▲ 16.8%
841.66M▲ 171.4%
995.91M▲ 18.3%
1.13B▲ 13.7%
1.4B▲ 24.0%
1.49B▲ 5.8%
Equity Growth %-16.84%171.38%18.33%13.73%23.99%5.8%
Book Value per Share1.001.173.183.764.275.155.44
Total Shareholders' Equity265.49M310.5M842.07M996.13M1.13B1.4B1.49B
Common Stock20M20M21.7M21.7M21.7M22.23M22.22M
Retained Earnings000623.35M757.86M863.44M876.41M
Treasury Stock000-27.74M-27.23M-27.15M-27.07M
Accumulated OCI206.29M211.98M686.05M-10.49M-9.11M-13.75M54.95M
Minority Interest-50K-355K-415K-220K115K46K37.98K

STVN Cash Flow Statement

Stevanato Group S.p.A. (STVN) cash flow — operating, investing & free cash flow history

Line itemDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Cash from Operations42.57M155.66M133.34M103.31M105.21M155.78M274.79M
Operating CF Margin %7.93%23.51%15.8%10.5%9.69%14.11%24.12%
Operating CF Growth %-265.63%-14.34%-22.52%1.84%48.06%76.4%
Net Income54.71M96.28M165.67M187.64M189.55M160.29M134.32M
Depreciation & Amortization46.22M54.1M56.38M64.82M78.48M80.65M83.9M
Stock-Based Compensation0000000
Deferred Taxes0000000
Other Non-Cash Items-33.39M-27.9M-47.09M-31.41M-60.34M-67.76M7.94M
Working Capital Changes-24.97M33.18M-41.63M-117.74M-102.48M-17.41M48.63M
Change in Receivables5.87M-3.63M-54.77M-46.42M-93.86M-3.83M855.83K
Change in Inventory-42.67M-15.6M-31.2M-107.37M-113.59M12.31M-39.82M
Change in Payables11.84M52.41M44.34M36.05M104.97M-25.89M87.59M
Cash from Investing-74.34M-96.09M-96.43M-242.95M-421.22M-310.21M-262.15M
Capital Expenditures-68.09M-89.56M-107.69M-235.03M-433.23M-302.6M-264.18M
CapEx % of Revenue12.69%13.53%12.76%23.89%39.92%27.41%23.18%
Acquisitions0014.81M0-3.59M-175K1.79M
Investments-------
Other Investing-5.62M-6.42M-4.32M-7.95M15.6M-7.44M0
Cash from Financing42.17M-26.52M254.85M-44.54M158.03M183.22M21.19M
Debt Issued (Net)48.34M-17.08M-120.18M-31.04M172.57M27.91M41.38M
Equity Issued (Net)00380.09M00169.77M0
Dividends Paid-6.17M-8.9M-11.2M-13.5M-14.29M-14.46M-14.16M
Share Repurchases0000000
Other Financing0-539K6.13M0-250K0-6.03M
Net Change in Cash
10.87M▲ 0%
30.21M▲ 178.0%
295.44M▲ 877.9%
-182.3M▼ 161.7%
-159.14M▲ 12.7%
28.67M▲ 118.0%
43.94M▲ 53.3%
Free Cash Flow
-31.33M▲ 0%
59.65M▲ 290.4%
20.16M▼ 66.2%
-139.81M▼ 793.7%
-336.72M▼ 140.8%
-157.79M▲ 53.1%
21.44M▲ 113.6%
FCF Margin %-5.84%9.01%2.39%-14.21%-31.02%-14.29%1.88%
FCF Growth %-290.37%-66.21%-793.66%-140.83%53.14%113.59%
FCF per Share-0.120.230.08-0.53-1.27-0.580.08
FCF Conversion (FCF/Net Income)1.09x1.98x0.99x0.72x0.72x1.32x2.05x
Interest Paid0000000
Taxes Paid0000000

STVN Key Ratios

Stevanato Group S.p.A. (STVN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric2019202020212022202320242025
Return on Equity (ROE)14.77%27.28%23.32%15.55%13.68%9.28%9.29%
Return on Invested Capital (ROIC)8.4%13.89%19.74%17.38%12.31%7.57%7.71%
Gross Margin25.72%29.33%31.45%32.51%31.32%27.38%28.99%
Net Margin7.31%11.86%15.92%14.52%13.42%10.67%11.78%
Debt / Equity1.42x1.17x0.29x0.22x0.35x0.31x0.32x
Interest Coverage11.38x15.06x35.01x48.67x44.93x24.35x8.40x
FCF Conversion1.09x1.98x0.99x0.72x0.72x1.32x2.05x
Revenue Growth-23.39%27.47%16.56%10.34%1.72%3.21%

STVN Frequently Asked Questions

Stevanato Group S.p.A. (STVN) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Stevanato Group S.p.A. (STVN) reported $1.18B in revenue for fiscal year 2025. This represents a 120% increase from $536.5M in 2019.

Stevanato Group S.p.A. (STVN) grew revenue by 3.2% over the past year. Growth has been modest.

Yes, Stevanato Group S.p.A. (STVN) is profitable, generating $139.4M in net income for fiscal year 2025 (11.8% net margin).

Dividend & Returns

Yes, Stevanato Group S.p.A. (STVN) pays a dividend with a yield of 0.32%. This makes it attractive for income-focused investors.

Stevanato Group S.p.A. (STVN) has a return on equity (ROE) of 9.3%. This is below average, suggesting room for improvement.

Stevanato Group S.p.A. (STVN) generated $16.2M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More STVN

Stevanato Group S.p.A. (STVN) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.